Literature DB >> 35075086

Degenerative meniscal lesions: Conservative versus surgical management.

Ibrahim Akkawi1, Maurizio Draghetti2, Hassan Zmerly3.   

Abstract

Degenerative meniscal lesions (DML) typically occur in middle-aged or elderly patients without any history of significant acute trauma. Its prevalence increases with age and are associated with knee osteoarthritis (OA). The most frequent orthopaedic treatment is arthroscopic partial meniscectomy (APM) to relieve pain and functional deficit associated with DML. Nevertheless, several randomised controlled clinical trials recommed against APM as the first-line treatment for managing knee pain in patients affected by DML and no radiographic knee OA that should be reserved for cases of failure after 3 month conservative therapy or earlier in patients with signficant knee mechanical symptoms.

Entities:  

Mesh:

Year:  2022        PMID: 35075086      PMCID: PMC8823549          DOI: 10.23750/abm.v92i6.11195

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


Introduction

Menisci has numerous functions, such as load-bearing, load transmission, shock absorption, stabilization of the knee during movement and loading, and lubrication of the knee joint (1, 2). Meniscal lesions are the second most frequent injury of the knee (3). These injuries can be divided into two groups: traumatic and degenerative lesions (3). Degenerative meniscal lesions (DML) typically occurs in middle-aged patients without any history of significant acute trauma (4). Its prevalence increases with age and are associated with knee osteoarthritis (OA) (2, 5, 6). Older age, male sex, body mass index> 25, work related kneeling or squatting, and ascending stairs are risk factors for DML (7). Patient history and findings from clinical examination are fundamental for the clinical diagnosis of DML (5). Signs and symtoms of DML includes: recent onset of knee pain, locking, catching sensation, effusion, swelling, clicking, popping, buckling, and giving way (4, 7). Furthermore, McMurray test, Apley grind test, the presence of joint line soreness and lack of complete extension can be helpful in the evaluation of symptomatic DML (8). Nevertheless, all these signs and symptoms are not specific and have limited diagnostic accuracy (7). Weight-bearing knee radiographs is the first line imaging modality for the assessment of middle-aged patients with painful knee to exclude other sources of knee pain, such as osteoarthritis (9). Whereas, MRI is indicated when knee radiographs do not show OA and a meniscal lesion is suspected to assess not only its presence, but also its location, extension and displacement (3). The most frequent orthopedic treatment is arthroscopic surgery to relieve pain associated with DML. In the United States, approximately 700 000 arthroscopic partial meniscectomies for DML are carried out annually (10). The efficacy of this technique, however, has been questioned by recent evidence from several randomized controlled trials (RCTs) (8). Therefore, the aim of the present narrative review is to focus on the guidelines of DML treatment in middle-aged patients.

Methods

A review was conducted of PubMed articles from January 1, 2000 to December 31, 2020 using a combination of the following keywords: knee, osteoarthritis, degenerative meniscal lesion, degenerative meniscal tear, and arthroscopic partial meniscectomy (APM). The most relevant and recent RCTs and case series focusing on the guidelines of DML treatment were reviewed. Additional studies have been found by examining the reference lists of the above articles. Exclusion criteria were: traumatic meniscal lesion, non English, and case report studies.

Results

A total of 12 papers (1, 3, 10-19) were included in the present narrative review. Of these, 3 papers (1, 3, 11) assessed the clinical outcome of patients with DML treated conservatively and 9 papers (10, 12–19) compared the clinical outcome of patients with DML, with or without mechanical symptoms, treated with APM versus physical therapy (12–15, 19) or APM versus sham surgery (10, 16–18). Ten papers (3, 10, 12–19) were RCTs (Level of Evidence I), and two studies (1, 11) were prospective case series (Level of Evidence IV). A summary of these studies is shown in Table 1 and Table 2.
Table 1.

Details of studies assessing patients with DML treated conservatively.

AuthorType of studyTreatmentClinical scoresPatientsMean age, yearsLatest followup, months
Zorzi et al. 2016 (3)RCTIA injections + conservative therapy (ice applications, rest and knee off-loading and paracetamol intake as needed) vs conservative therapySF-36, WOMAC, VAS25 vs 1730 vs 332
Mitev et al 2019 (11)Case seriesPRP injectionsTLK1549,36
Berton et al. 2020 (1)Case seriesIA injectionsSF-36, PPtGA, CoGA, WOMAC40472

Abbreviations: SF-36, Short Form-36; WOMAC, Western Ontario and Mc Master University; VAS, Visual Analog Scale; TLK, Tegner Lysholm Knee; PtGA, Patient’s Global Assessment; CoGA, Clinical Observer Global Assessment.

Table 2.

Details of studies assessing patients with DML with or without mechanical symptoms treated with APM versus conservative therapy or APM vs sham surgery. * value reported as range of all patients.

AuthorType of studyTreatmentClinical scoresPatientsMean age yearsFinal followup months
Kirkley et al. 2008 (12)RCTAPM + physical and pharmacological therapy vs physical and pharmacological therapySF-36, WOMAC92 vs 8658,6 vs 60,624
Herrlin et al. 2012 (15)RCTAPM + physical therapy vs physical therapyKOOS, VAS, LK, TAS45 vs 4754 vs5660
Katz et al. 2013 (13)RCTAPM + physical therapy vs physical therapySF-36, KOOS, WOMAC174 vs 17759 vs 57,812
Yim et al. 2013 (14)RCTAPM + physical and medical therapy vs physical and medical therapyVAS, LK, TAS50 vs 5254,9 vs 57,624
Sihvonen et al. 2013 (16)RCTAPM vs sham surgeryWOMET, VAS, LK70 vs 7652 vs 5212
Sihvonen et al. 2016 (10)RCTAPM vs sham surgeryLK70 vs 7652 vs 5212
Gauffin et al. 2017 (19)RCTAPM vs physical therapyEQ-5D, EG-VAS, KOOS75 vs 7545-54*36
Sihvonen et al. 2018 (17)RCTAPM vs sham surgeryWOMET, VAS, LK70 vs 7652 vs 5224
Sihvonen et al. 2020 (18)RCTAPM vs sham surgeryWOMET, VAS, LK70 vs 7652 vs 5260

Abbreviations: KOOS, Knee Osteoarthritis and Injury Outcome Score; WOMAC, Western Ontario and Mc Master University; TLK, Tegner Lysholm Knee; LK, Lysholm Knee; TAS, Tegner Activity Scale; EQ-5D, EuroQol 5D; EQ-VAS, EuroQol visual analog scale; SF.36, Short Form-36; WOMET, Western Ontario Meniscal Evaluation Tool.

Details of studies assessing patients with DML treated conservatively. Abbreviations: SF-36, Short Form-36; WOMAC, Western Ontario and Mc Master University; VAS, Visual Analog Scale; TLK, Tegner Lysholm Knee; PtGA, Patient’s Global Assessment; CoGA, Clinical Observer Global Assessment. Details of studies assessing patients with DML with or without mechanical symptoms treated with APM versus conservative therapy or APM vs sham surgery. * value reported as range of all patients. Abbreviations: KOOS, Knee Osteoarthritis and Injury Outcome Score; WOMAC, Western Ontario and Mc Master University; TLK, Tegner Lysholm Knee; LK, Lysholm Knee; TAS, Tegner Activity Scale; EQ-5D, EuroQol 5D; EQ-VAS, EuroQol visual analog scale; SF.36, Short Form-36; WOMET, Western Ontario Meniscal Evaluation Tool.

Discussion

Conservative therapy

At present, the treatment of DML in middle-aged patients remains problematic. Conservative therapy includes analgesics, non-steroidal anti-inflammatory drugs, glucocorticoid injections, physical therapy, weight loss, and avoiding specific movements that worsen symptoms (7). Both hyaluronic acid (HA) and platelet-rich plasma (PRP) injections are also valid alternatives for DML treatment. Mitev et al. (11) showed that PRP therapy of 126 patients with DML resulted in improvement 3 months after the PRP application, and the findings remained the same 6 months after the application. HA injections has been shown to be successful also in the treatment of DML by inducing meniscal regeneration through inhibiting apoptosis, facilitating cell migration, and accelerating cell proliferation (1, 3). Berton et al. (1) conducted a prospective pilot study to determine the clinical efficacy of HA injections in 40 patients with DML and no knee OA. All clinical scores showed a statistically significant difference between baseline and 60 days follow-up. Meniscal healing, measured by a decrease in the T2 measurement on quantitative MRI, at 60 days follow-up was detected in the posterior horn of the medial meniscus in 39% of cases in both the red and red–white zone, and in 60% of cases in the white zone, while in the posterior horn of the lateral meniscus it was detected in 55% of cases in both the red and white zones, and in 65% of cases in the red–white zone. Similarly, Zorzi et al. (3) performed a recent RCT to investigate the effectiveness of intra-articular injection of HA plus conservative therapy compared to a control group who received only conservative therapy in 50 patients with DML and no radiographic knee OA. They observed a significant reduction in VAS score, and meniscal lesion length and depth, measured by MRI, in the HA group compared to the control group.

Surgery

Each year, more than half a million patients undergo APM in the United States (18). However, there is disagreement about APM's benefit over conservative therapy or sham surgery for middle-aged patients affected by DML as shown by a recent systematic review of 10 RCTs (20).

APM vs physical therapy

DML in the presence of knee OA should be managed by conservative therapy rather than APM as indicated by international recommendations (21). In fact, according to ESSKA recommendations (5), APM should not be undertaken for DML with advanced radiographic knee OA (Kellgren–Lawrence (KL) grade II or more [22]). The reason is that, DML is mostly asymptomatic and knee pain is related to knee OA and not to DML (8). Kirkley et al. (12) conducted a single center RCT to evaluate the outcome of APM plus physical and pharmacological therapy (surgery group) versus physical and pharmacological therapy alone (control group) in patients with DML and moderate-to-severe knee OA (KL grade II–IV) at a follow-up of 3, 6, 12, 18, and 24 months. At 3 months, they observed that clinical scores in the surgery group had improved more than those in the control group that they attribuited it to a probable placebo effect, however, there were no significant differences between the groups during the subsequent visits concluding that APM for DML associated with knee OA give no added advantage to physical and pharmacological therapy. Similarly Katz et al. (13) conducted a multicenter RCT of 351 patients with DML and associated mild-to-moderate knee OA (KL grade 0–III) treated with APM plus physical therapy versus physical therapy only. They found no significant differences between the study groups in functional improvement 6 and 12 months after treatment. Recent studies have demonstrated that even in the absence of radiographic signs of knee OA, there was no advantage of APM over conservative therapy of patients with DML (21). In deed, Yim et al. (14) published a RCT to determine the clinical results of APM (followed by physical and medical therapy) compared to conservative therapy (physical and medical therapy alone) in 102 patients with DML and no radiographic knee OA. The authors found no significant differences between the two groups in terms of reduction of knee pain, enhanced knee function, or increased patient satisfaction after 2 years of follow-up. Herrlin et al. (15) performed a RCT to assess the outcome of APM plus physical therapy compared to physical therapy alone when treating DML without radiographic knee OA. Both groups demonstrated substantial clinical improvements from baseline to 24 and 60 months follow-up, but, no group differences were found concluding that APM accompanied by physical therapy was not better than physical therapy alone. Thus, physical therapy should be recommended as initial treatment for this cohort of patients. These findings are supported by the ESSKA meniscal consensus (5) which recommends that in the treatment of patients with a symptomatic knee and DML without radiographic knee OA, APM should not be proposed as a first-line treatment, but after 3 months of persistent symptoms despite conservative therapy.

APM vs sham surgery

APM offer no further advantage for knee symptoms or function compared with sham surgery. Sihvonen et al. (16) conducted a multicenter, double-blind, RCT to determine the 12 months effectiveness of APM compared to sham surgery (APM was simulated) in 146 symptomatic patients with DML and no radiographic knee OA. At follow-up, no major clinical outcome differences between groups were found. Furthermore, no major differences in the number of patients needing additional knee surgery or severe adverse effects were found within the groups. The same authors found similar results at a followup of 2 and 5 years (17, 18).

APM for DML with mechanical symptoms

Recent studies (10, 17–19) questioned the validity of pre-operative mechanical symptoms (knee locking and catching) or unstable lesions as an indication for APM in patients with DML and no radiographic knee OA. Sihvonen et al. (10) in a double blinded RCT showed that APM has no additional advantage over sham surgery in relieving knee catching or occasional locking at 12 months follow-up. The same authors (17, 18) confirmed these results at 24 e 60 months follow-up. The same results were observed in another RCT by Gauffin et al. (19) who reported that patients with DML, no radiographic knee OA, and the presence of mechanical symptoms treated with APM had less benefit than patients without mechanical symptoms. These studies excluded significant major knee mechanical symptoms as locked knee and joint locking for more than 2 seconds more often than once a week. In these cases, patients could benefit from surgery even before 3 months period of conservative therapy as suggested by ESSKA consensus (5).

Prognostic factors of poor results after APM for DML

Numerous predictive factors of poor results after APM for DML have been identified in the current literature. In a prospective cohort study, Lizaur-Utrilla et al. (4) observed that the predictors of dissatisfaction among middle-aged patients treated with APM for DML with no knee OA were female sex, obesity, and lateral meniscal lesions. Vermesan et al. (23) reported that meniscal extrusion, bone marrow edema, duration of the clinical symptoms, obesity and a low pre-operative score were negative prognostic factors. A cohort analysis was undertaken by Kise et al. (24) to examine prognostic factors of pre-operative findings from MRI and arthroscopic assessment on patient-reported outcomes post APM. They found that complex meniscal lesions, larger extrusion, cartilage injuries, and larger meniscectomy were clinically significant prognostic factors for poorer outcomes 1 and 2 years post APM. Finally, in a recent retrospective study (25) of 160 patients aged between 50 and 70 years with diagnosis of DML and no or early stage knee OA (KL grade ≤2) who underwent APM, the authors found a statistically significant association between knee OA (KL grade 2), advanced chondral lesion (Outerbridge>2), lateral meniscectomy, age at surgery, female sex and malalignment and poor clinical outcome at final followup.

Conclusions

The findings of the present narrative review, suggest that the practice of APM should be proposed for patients suffering from knee pain and functional impairment due to DML with no radiographic knee OA and refractory to a 3 months period of conservative therapy or earlier in patients with major knee mechanical symptoms. Furthermore, surgeons should counsel patients that surgical treatment in the presence of negative prognostic factors is associated with poor clinical outcome.
  25 in total

1.  Arthroscopic or conservative treatment of degenerative medial meniscal tears: a prospective randomised trial.

Authors:  Sylvia Herrlin; Maria Hållander; Peter Wange; Lars Weidenhielm; Suzanne Werner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-01-10       Impact factor: 4.342

2.  National consensus on the definition, investigation, and classification of meniscal lesions of the knee.

Authors:  S G F Abram; D J Beard; A J Price
Journal:  Knee       Date:  2018-07-06       Impact factor: 2.199

3.  Complex Tears, Extrusion, and Larger Excision Are Prognostic Factors for Worse Outcomes 1 and 2 Years After Arthroscopic Partial Meniscectomy for Degenerative Meniscal Tears: A Secondary Explorative Study of the Surgically Treated Group From the Odense-Oslo Meniscectomy Versus Exercise (OMEX) Trial.

Authors:  Nina Jullum Kise; Cathrine Aga; Lars Engebretsen; Ewa M Roos; Rana Tariq; May Arna Risberg
Journal:  Am J Sports Med       Date:  2019-07-12       Impact factor: 6.202

Review 4.  Effectiveness of exercise therapy for meniscal lesions in adults: A systematic review and meta-analysis.

Authors:  N M Swart; K van Oudenaarde; M Reijnierse; R G H H Nelissen; J A N Verhaar; S M A Bierma-Zeinstra; P A J Luijsterburg
Journal:  J Sci Med Sport       Date:  2016-04-20       Impact factor: 4.319

Review 5.  Management of traumatic meniscal tear and degenerative meniscal lesions. Save the meniscus.

Authors:  P Beaufils; N Pujol
Journal:  Orthop Traumatol Surg Res       Date:  2017-09-02       Impact factor: 2.256

6.  Outcomes and Patient Satisfaction With Arthroscopic Partial Meniscectomy for Degenerative and Traumatic Tears in Middle-Aged Patients With No or Mild Osteoarthritis.

Authors:  Alejandro Lizaur-Utrilla; Francisco A Miralles-Muñoz; Santiago Gonzalez-Parreño; Fernando A Lopez-Prats
Journal:  Am J Sports Med       Date:  2019-06-28       Impact factor: 6.202

7.  Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear.

Authors:  Raine Sihvonen; Mika Paavola; Antti Malmivaara; Ari Itälä; Antti Joukainen; Heikki Nurmi; Juha Kalske; Teppo L N Järvinen
Journal:  N Engl J Med       Date:  2013-12-26       Impact factor: 91.245

Review 8.  The role of the meniscus in osteoarthritis genesis.

Authors:  Martin Englund
Journal:  Rheum Dis Clin North Am       Date:  2008-08       Impact factor: 2.670

9.  Arthroscopic partial meniscectomy versus placebo surgery for a degenerative meniscus tear: a 2-year follow-up of the randomised controlled trial.

Authors:  Raine Sihvonen; Mika Paavola; Antti Malmivaara; Ari Itälä; Antti Joukainen; Heikki Nurmi; Juha Kalske; Anna Ikonen; Timo Järvelä; Tero A H Järvinen; Kari Kanto; Janne Karhunen; Jani Knifsund; Heikki Kröger; Tommi Kääriäinen; Janne Lehtinen; Jukka Nyrhinen; Juha Paloneva; Outi Päiväniemi; Marko Raivio; Janne Sahlman; Roope Sarvilinna; Sikri Tukiainen; Ville-Valtteri Välimäki; Ville Äärimaa; Pirjo Toivonen; Teppo L N Järvinen
Journal:  Ann Rheum Dis       Date:  2017-05-18       Impact factor: 19.103

10.  Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.

Authors:  Raine Sihvonen; Mika Paavola; Antti Malmivaara; Ari Itälä; Antti Joukainen; Juha Kalske; Heikki Nurmi; Jaanika Kumm; Niko Sillanpää; Tommi Kiekara; Aleksandra Turkiewicz; Pirjo Toivonen; Martin Englund; Simo Taimela; Teppo L N Järvinen
Journal:  Br J Sports Med       Date:  2020-08-27       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.